Pathalys Pharma
Clinical trials sponsored by Pathalys Pharma, explained in plain language.
-
New drug shows promise for dialysis patients with hormone imbalance
Disease control CompletedThis study tested a new medicine called PLS240 in 412 adults with end-stage kidney disease on dialysis who also have overactive parathyroid glands (secondary hyperparathyroidism). The goal was to see if PLS240 can safely lower high parathyroid hormone levels better than a placebo…
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated May 17, 2026 11:18 UTC
-
New drug aims to tame parathyroid glands in dialysis patients
Disease control CompletedThis study tested a drug called PLS240 in 362 adults with end-stage kidney disease on dialysis who also have overactive parathyroid glands (secondary hyperparathyroidism). The goal was to see if PLS240 can safely lower high parathyroid hormone levels. Participants received either…
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated May 06, 2026 16:01 UTC